急性肠系膜缺血开放血运重建术后30天结局:ACS-NSQIP分析
基于ACS-NSQIP数据库2005-2017年918例因急性肠系膜缺血行开放血运重建的患者,回顾性分析显示30天死亡率为32%,其中取栓术后35%、血栓内膜切除术后31%、肠系膜旁路术后28%。需要同期肠切除者死亡率更高(38% vs. 29%,P<0.01)。播散性癌症是与30天死亡率独立相关最强的术前因素(OR=8.8,95%CI=2.4-32,P=0.001)。
要点
- 开放血运重建治疗急性肠系膜缺血30天死亡率高达32%。
- 同期肠切除者死亡率显著高于未切除者(38% vs. 29%,P<0.01)。
- 播散性癌症、肾功能障碍、术前插管等是独立死亡危险因素。
核心结论
- 开放血运重建治疗急性肠系膜缺血与高死亡率相关,近三分之一患者在术后30天内死亡。
- 播散性癌症、术前肾功能障碍和术前白细胞升高是术前风险分层的重要工具。
研究设计与样本
- 回顾性队列研究,使用美国外科医师学会国家手术质量改进计划(ACS-NSQIP)数据库2005-2017年数据。
- 纳入918例因急性肠系膜缺血行开放肠系膜血运重建的患者,中位年龄70岁(IQR 59-80),62%为女性,90%为白人。
主要发现
- 30天死亡率为32%,取栓术后35%,血栓内膜切除术后31%,肠系膜旁路术后28%。
- 需要同期肠切除的患者死亡率高于不需要者(38% vs. 29%,P<0.01)。
- 播散性癌症与30天死亡率独立相关(OR=8.8,95%CI=2.4-32,P=0.001)。
- 其他独立相关因素包括肾功能障碍、术前插管、术前输血、糖尿病、术前INR升高、术前白细胞升高和年龄增加。
临床怎么用
- 对于急性肠系膜缺血拟行开放血运重建的患者,应术前评估播散性癌症、肾功能障碍、术前插管、输血、糖尿病、INR升高、白细胞升高和年龄等风险因素。
- 播散性癌症患者术后30天死亡风险显著增高(OR=8.8),需强化术前沟通和围术期管理。
局限性
- 回顾性队列研究设计可能引入选择偏倚和混杂偏倚。
- 数据库可能缺乏急性肠系膜缺血严重程度、缺血时间和血运重建技术细节等信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Open revascularization for acute mesenteric ischemia (AMI) is associated with high perioperative morbidity and mortality; however, results from contemporary studies are varied. Therefore, we evaluated 30-day mortality after open revascularization for AMI and identified preoperative factors associated with mortality. METHODS: We performed a retrospective cohort study of patients in the American College of Surgeons National Surgical Quality Improvement Program database undergoing open mesenteric revascularization for AMI from 2005 to 2017. The primary outcome was 30-day mortality. We used multivariable logistic regression to identify preoperative factors independently associated with 30-day mortality. RESULTS: The study cohort included 918 patients; their median age was 70 years (interquartile range: 59-80 years), 62% were female, and 90% were white. Thirty-day mortality after open revascularization for AMI was 32%, specifically 35% after embolectomy, 31% after thromboendarterectomy, and 28% after mesenteric bypass. Mortality was higher in patients requiring concomitant bowel resection (38% vs. 29%, respectively, P < 0.01). The preoperative factor most strongly associated with 30-day mortality was disseminated cancer (odds ratio = 8.8, 95% confidence interval = 2.4-32, P = 0.001). Other factors independently associated with mortality were renal dysfunction, preoperative intubation, preoperative blood transfusion, diabetes, elevated preoperative international normalized ratio, elevated preoperative white blood cell count, and increasing age. CONCLUSIONS: In this retrospective cohort study using a real-world, nationwide cohort, open revascularization for AMI was associated with high mortality, with nearly one-third of patients dying within 30 days of their operation. The factors identified to be independently associated with 30-day mortality, particularly disseminated cancer, preoperative renal dysfunction, and elevated preoperative WBC count, are an important tool for preoperative risk stratification.
引用
- Swerdlow NJ, Varkevisser RRB, Soden PA, et al. Thirty-Day Outcomes After Open Revascularization for Acute Mesenteric Ischemia From the American College of Surgeons National Surgical Quality Improvement Program. Ann Vasc Surg. 2019. PMID: 31382003. doi:10.1016/j.avsg.2019.05.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。